WGU D116 ADVANCED PHARMACOLOGY OA 2026/2027 NEWEST ACTUAL EXAM 2 VERSIONS COMPLETE 300 QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

WGU D116 ADVANCED PHARMACOLOGY OA
2026/2027 NEWEST ACTUAL EXAM 2 VERSIONS
COMPLETE 300 QUESTIONS AND CORRECT
DETAILED ANSWERS WITH RATIONALES
(VERIFIED ANSWERS) |ALREADY GRADED A+

WGU D116 OA VERSION A

1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion (ADME)
C) The study of drug toxicity
D) The study of drug interactions
Answer B: The study of drug absorption, distribution, metabolism, and
excretion (ADME)
Rationale: Pharmacokinetics is "what the body does to the drug" (ADME).
Pharmacodynamics is "what the drug does to the body."




2. The "first-pass effect" refers to:
A) Rapid intravenous administration
B) Drug metabolism in the liver before reaching systemic circulation (primarily oral
drugs)

,C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
Answer B: Drug metabolism in the liver before reaching systemic circulation
(primarily oral drugs)
Rationale: The first-pass effect reduces bioavailability of oral drugs; some drugs
require higher oral doses or alternative routes to bypass this effect.




3. Bioavailability is defined as:
A) The speed of drug absorption
B) The fraction of an administered dose that reaches systemic circulation
unchanged
C) The volume of distribution
D) The half-life of the drug
Answer B: The fraction of an administered dose that reaches systemic
circulation unchanged
Rationale: IV administration has 100% bioavailability; oral bioavailability is
reduced by first-pass metabolism and absorption barriers.




4. Which route of administration has the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous (IV)
D) Intramuscular (IM)

,Answer C: Intravenous (IV)
Rationale: IV administration bypasses absorption barriers and first-pass
metabolism, delivering 100% of the dose to systemic circulation.




5. The volume of distribution (Vd) of a drug that is highly tissue-bound will
be:
A) Low
B) High
C) Zero
D) Negative
Answer B: High
Rationale: High Vd indicates extensive tissue binding; low Vd indicates primarily
plasma binding. Vd affects loading dose calculations.




6. A drug with a high volume of distribution (e.g., digoxin) is characterized
by:
A) High plasma concentration
B) Low plasma concentration (distributes widely into tissues)
C) Rapid renal excretion
D) Minimal tissue binding
Answer B: Low plasma concentration (distributes widely into tissues)
Rationale: High Vd means most drug is in tissues, not plasma; this requires large
loading doses to achieve therapeutic plasma levels.

, 7. The half-life (t½) of a drug is:
A) The time required for 50% of the drug to be eliminated
B) The time for plasma concentration to decrease by 50%
C) The time between doses
D) The time to eliminate the drug completely
Answer B: The time for plasma concentration to decrease by 50%
Rationale: Half-life determines dosing interval; it takes approximately 4-5 half-
lives to reach steady state and to eliminate the drug.




8. Steady state of a drug is typically reached after approximately:
A) One half-life
B) 2-3 half-lives
C) 4-5 half-lives
D) 10 half-lives
Answer C: 4-5 half-lives
Rationale: Steady state is reached when rate of drug administration equals rate of
elimination, usually after 4-5 half-lives. For a drug with a 24-hour half-life, steady
state is reached in about 5 days.




9. The loading dose of a drug is intended to:
A) Maintain steady state